Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911116 | Lung Cancer | 2014 | 6 Pages |
Abstract
The utility gained from surgical operation for operable lung cancer is substantial, even after adjustment for lead-time bias. Future studies should compare screening programs with treatment strategies when carrying out cost-utility assessments to improve patients' values.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Szu-Chun Yang, Wu-Wei Lai, Han-Yu Chang, Wu-Chou Su, Helen H.W. Chen, Jung-Der Wang,